Anemia in chronic kidney disease. Anemia in chronic kidney disease
Conditions
Interventions
Intervention 1: Intervention group: Thirty patients underwent hemodialysis for 6 months, and for the treatment of anemia during these six months, they were treated with Aprex 4000 ampoules three times
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age over 18 years Patients undergoing dialysis more than or equal to 3 times a week for more than or equal to 90 days Receive standard treatment for anemia (erythropoietin and Venofer ampoules) for at least three months Life expectancy of more than 6 months Absence of gastrointestinal disease or surgery that affects the absorption of vitamin D. Intact Parathyroid Hormone(IPTH)= 150-350pg/ml
Exclusion criteria
Exclusion criteria: Hemoglobinopathy Chronic liver disease Dissatisfaction of patient companions Patients who do not return one month later pregnancy Dialysis adequacy is less than 1.4 in the last three months Transfusion over the past three months Hypercalcemia over the past month (> 10) Hyperphosphatemia over the past month (> 5)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin level. Timepoint: One and three months after the start of the trial. Method of measurement: Complete Blood Count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Salarian
Shahid Beheshti University of Medical Sciences
Outcome results
None listed